{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T13:02:43Z","timestamp":1780146163104,"version":"3.54.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,30]]},"DOI":"10.7759\/cureus.109923","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T12:53:37Z","timestamp":1780145617000},"source":"Crossref","is-referenced-by-count":0,"title":["Role of the Fungal Serological Marker Galactomannan Antigen in the Diagnosis of Invasive Fungal Infection: A Three-Year Retrospective Study"],"prefix":"10.7759","author":[{"given":"Smrutisree","family":"Mohapatra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunalsen","family":"Jagatdeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishikanta","family":"Thatoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishikanta","family":"Muduli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basanti Kumari","family":"Pathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumudini","family":"Panigrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1084666","article-title":"Invasive fungal disease in COVID-19 patients: a single-center prospective observational study","volume":"10","author":"Adzic-Vukicevic T","year":"2023","unstructured":"Adzic-Vukicevic T, Mladenovic M, Jovanovic S, Soldatovi\u0107 I, Radovanovic-Spurnic A. Invasive fungal disease in COVID-19 patients: a single-center prospective observational study. Front Med (Lausanne). 2023, 10:1084666. 10.3389\/fmed.2023.1084666","journal-title":"Front Med (Lausanne)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1435239","article-title":"A rare intestinal mucormycosis caused by Lichtheimia ramosa in a patient with diabetes: a case report","volume":"11","author":"Liu Q","year":"2024","unstructured":"Liu Q, Chen P, Xin L, Zhang J, Jiang M. A rare intestinal mucormycosis caused by Lichtheimia ramosa in a patient with diabetes: a case report. Front Med (Lausanne). 2024, 11:1435239. 10.3389\/fmed.2024.1435239","journal-title":"Front Med (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning DW","year":"2024","unstructured":"Denning DW. Global incidence and mortality of severe fungal disease. Lancet Infect Dis. 2024, 24:428-38. 10.1016\/S1473-3099(23)00692-8","journal-title":"Lancet Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2021.08.002","article-title":"Nosocomial fungal infections: epidemiology, infection control, and prevention","volume":"35","author":"Suleyman G","year":"2021","unstructured":"Suleyman G, Alangaden GJ. Nosocomial fungal infections: epidemiology, infection control, and prevention. Infect Dis Clin North Am. 2021, 35:1027-53. 10.1016\/j.idc.2021.08.002","journal-title":"Infect Dis Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myad021","article-title":"Real-life epidemiology and current outcomes of hospitalized adults with invasive fungal infections","volume":"61","author":"Monz\u00f3-Gallo P","year":"2023","unstructured":"Monz\u00f3-Gallo P, Chumbita M, Lopera C, et al.. Real-life epidemiology and current outcomes of hospitalized adults with invasive fungal infections. Med Mycol. 2023, 61:10.1093\/mmy\/myad021","journal-title":"Med Mycol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_1582_24","article-title":"Invasive fungal infections and the management in immunocompromised conditions","volume":"14","author":"Anandani G","year":"2025","unstructured":"Anandani G, Bhise M, Agarwal A. Invasive fungal infections and the management in immunocompromised conditions. J Family Med Prim Care. 2025, 14:2643-52. 10.4103\/jfmpc.jfmpc_1582_24","journal-title":"J Family Med Prim Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200007000-00006","article-title":"Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group","volume":"79","author":"Patterson TF","year":"2000","unstructured":"Patterson TF, Kirkpatrick WR, White M, et al.. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore). 2000, 79:250-60. 10.1097\/00005792-200007000-00006","journal-title":"Medicine (Baltimore)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.126698","article-title":"Epidemiology of invasive fungal disease in lymphoproliferative disorders","volume":"100","author":"Teng JC","year":"2015","unstructured":"Teng JC, Slavin MA, Teh BW, et al.. Epidemiology of invasive fungal disease in lymphoproliferative disorders. Haematologica. 2015, 100:e462-6. 10.3324\/haematol.2015.126698","journal-title":"Haematologica"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/03009734.2016.1237595","article-title":"Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?","volume":"122","author":"Svensson T","year":"2017","unstructured":"Svensson T, Lundstr\u00f6m KL, H\u00f6glund M, Cherif H. Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?. Ups J Med Sci. 2017, 122:56-60. 10.1080\/03009734.2016.1237595","journal-title":"Ups J Med Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3109\/13693786.2010.505204","article-title":"Clinical risk factors for invasive aspergillosis","volume":"49","author":"Baddley JW","year":"2011","unstructured":"Baddley JW. Clinical risk factors for invasive aspergillosis. Med Mycol. 2011, 49:S7-12. 10.3109\/13693786.2010.505204","journal-title":"Med Mycol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12598","article-title":"Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation","volume":"44","author":"Blyth CC","year":"2014","unstructured":"Blyth CC, Gilroy NM, Guy SD, et al.. Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation. Intern Med J. 2014, 44:1333-49. 10.1111\/imj.12598","journal-title":"Intern Med J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12081","article-title":"Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study","volume":"56","author":"Lewis RE","year":"2013","unstructured":"Lewis RE, Cahyame-Zuniga L, Leventakos K, et al.. Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study. Mycoses. 2013, 56:638-45. 10.1111\/myc.12081","journal-title":"Mycoses"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/jof4030098","article-title":"Treatment of aspergillosis","volume":"4","author":"Jenks JD","year":"2018","unstructured":"Jenks JD, Hoenigl M. Treatment of aspergillosis. J Fungi (Basel). 2018, 4:10.3390\/jof4030098","journal-title":"J Fungi (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1586\/ehm.12.53","article-title":"Diagnostic methods for invasive fungal diseases in patients with hematologic malignancies","volume":"5","author":"Riwes MM","year":"2012","unstructured":"Riwes MM, Wingard JR. Diagnostic methods for invasive fungal diseases in patients with hematologic malignancies. Expert Rev Hematol. 2012, 5:661-9. 10.1586\/ehm.12.53","journal-title":"Expert Rev Hematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/jof2030022","article-title":"Galactomannan and 1,3-\u03b2-Dglucantesting for the diagnosis of invasive aspergillosis","volume":"2","author":"Lamoth F","year":"2016","unstructured":"Lamoth F. Galactomannan and 1,3-\u03b2-Dglucantesting for the diagnosis of invasive aspergillosis. J Fungi (Basel). 2016, 2:10.3390\/jof2030022","journal-title":"J Fungi (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/jof7020127","article-title":"The evolving landscape of fungal diagnostics, current and emerging microbiological approaches","volume":"7","author":"Freeman Weiss Z","year":"2021","unstructured":"Freeman Weiss Z, Leon A, Koo S. The evolving landscape of fungal diagnostics, current and emerging microbiological approaches. J Fungi (Basel). 2021, 7:10.3390\/jof7020127","journal-title":"J Fungi (Basel)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myy103","article-title":"How to make a fast diagnosis in invasive aspergillosis","volume":"57","author":"Lass-Fl\u00f6rl C","year":"2019","unstructured":"Lass-Fl\u00f6rl C. How to make a fast diagnosis in invasive aspergillosis. Med Mycol. 2019, 57:S155-60. 10.1093\/mmy\/myy103","journal-title":"Med Mycol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00237-8","article-title":"The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries","volume":"3","author":"Hoenigl M","year":"2022","unstructured":"Hoenigl M, Seidel D, Carvalho A, et al.. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet Microbe. 2022, 3:e543-52. 10.1016\/S2666-5247(21)00237-8","journal-title":"Lancet Microbe"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-018-3251-5","article-title":"Invasive pulmonary aspergillosis: current diagnostic methodologies and a new molecular approach","volume":"37","author":"Moura S","year":"2018","unstructured":"Moura S, Cerqueira L, Almeida A. Invasive pulmonary aspergillosis: current diagnostic methodologies and a new molecular approach. Eur J Clin Microbiol Infect Dis. 2018, 37:1393-403. 10.1007\/s10096-018-3251-5","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.04.007","article-title":"The utility of galactomannan antigen in the bronchial washing and serum for diagnosing pulmonary aspergillosis","volume":"107","author":"Kono Y","year":"2013","unstructured":"Kono Y, Tsushima K, Yamaguchi K, et al.. The utility of galactomannan antigen in the bronchial washing and serum for diagnosing pulmonary aspergillosis. Respir Med. 2013, 107:1094-100. 10.1016\/j.rmed.2013.04.007","journal-title":"Respir Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5455\/JPMA.1476","article-title":"Evaluation of galactomannan and beta-d-glucan assays for the diagnosis of invasive aspergillosis in clinically suspected cases","volume":"70","author":"Sarwar M","year":"2020","unstructured":"Sarwar M, Gardezi SA, Zaman G, Ikram A, Satti L, Khadim MT. Evaluation of galactomannan and beta-d-glucan assays for the diagnosis of invasive aspergillosis in clinically suspected cases. J Pak Med Assoc. 2020, 70:442-6. 10.5455\/JPMA.1476","journal-title":"J Pak Med Assoc"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-007-9010-2","article-title":"Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis","volume":"163","author":"Aquino VR","year":"2007","unstructured":"Aquino VR, Goldani LZ, Pasqualotto AC. Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis. Mycopathologia. 2007, 163:191-202. 10.1007\/s11046-007-9010-2","journal-title":"Mycopathologia"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12867","article-title":"False positive bronchoalveolar lavage galactomannan: effect of host and cut-off value","volume":"62","author":"Farmakiotis D","year":"2019","unstructured":"Farmakiotis D, Le A, Weiss Z, Ismail N, Kubiak DW, Koo S. False positive bronchoalveolar lavage galactomannan: effect of host and cut-off value. Mycoses. 2019, 62:204-13. 10.1111\/myc.12867","journal-title":"Mycoses"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007394.pub2","article-title":"Galactomannan detection for invasive aspergillosis in immunocompromised patients","volume":"2015","author":"Leeflang MM","year":"2015","unstructured":"Leeflang MM, Debets-Ossenkopp YJ, Wang J, et al.. Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst Rev. 2015, 2015:CD007394. 10.1002\/14651858.CD007394.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.95230","article-title":"A prospective observational study on the evaluation of the galactomannan test in the diagnosis of invasive aspergillosis","volume":"17","author":"Kumari P","year":"2025","unstructured":"Kumari P, Wadhwa T, Kumar A, Gaba M, Datta B. A prospective observational study on the evaluation of the galactomannan test in the diagnosis of invasive aspergillosis. Cureus. 2025, 17:e95230. 10.7759\/cureus.95230","journal-title":"Cureus"},{"key":"ref26","unstructured":"The R project for statistical computing. (2020). Accessed. April 4, 2026: http:\/\/www.r-project.org\/."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis DP","year":"2010","unstructured":"Kontoyiannis DP, Marr KA, Park BJ, et al.. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010, 50:1091-100. 10.1086\/651263","journal-title":"Clin Infect Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.06.021","article-title":"Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-\u03b2-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study","volume":"22","author":"Boch T","year":"2016","unstructured":"Boch T, Spiess B, Cornely OA, et al.. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-\u03b2-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study. Clin Microbiol Infect. 2016, 22:862-8. 10.1016\/j.cmi.2016.06.021","journal-title":"Clin Microbiol Infect"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.000512","article-title":"Effect of involved Aspergillus species on galactomannan in bronchoalveolar lavage of patients with invasive aspergillosis","volume":"66","author":"Taghizadeh-Armaki M","year":"2017","unstructured":"Taghizadeh-Armaki M, Hedayati MT, Moqarabzadeh V, et al.. Effect of involved Aspergillus species on galactomannan in bronchoalveolar lavage of patients with invasive aspergillosis. J Med Microbiol. 2017, 66:898-904. 10.1099\/jmm.0.000512","journal-title":"J Med Microbiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf620","article-title":"Prevalence and factors associated with Aspergillus galactomannan antigenemia among people with advanced HIV disease in Uganda, 2023","volume":"13","author":"Namuwenge PM","year":"2026","unstructured":"Namuwenge PM, Kyokushaba J, Kasone V, et al.. Prevalence and factors associated with Aspergillus galactomannan antigenemia among people with advanced HIV disease in Uganda, 2023. Open Forum Infect Dis. 2026, 13:ofaf620. 10.1093\/ofid\/ofaf620","journal-title":"Open Forum Infect Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2024.145208","article-title":"Sensitivity of serum galactomannan antigen in the diagnosis of invasive aspergillosis in patients with obstructive pulmonary diseases (asthma and chronic obstructive pulmonary diseases)","volume":"42","author":"Hu X","year":"2025","unstructured":"Hu X, Hu X, Zhu Y, Hu H, Wang Z. Sensitivity of serum galactomannan antigen in the diagnosis of invasive aspergillosis in patients with obstructive pulmonary diseases (asthma and chronic obstructive pulmonary diseases). Postepy Dermatol Alergol. 2025, 42:183-9. 10.5114\/ada.2024.145208","journal-title":"Postepy Dermatol Alergol"},{"key":"ref32","article-title":"The accuracy of serum galactomannan assay in diagnosing invasive pulmonary aspergillosis","author":"Sarrafzadeh SA","year":"2010","unstructured":"Sarrafzadeh SA, Rafati AH, Ardalan M, Mansouri D, Tabarsi P, Pourpak Z. The accuracy of serum galactomannan assay in diagnosing invasive pulmonary aspergillosis. Iran J Allergy Asthma Immunol. 2010, 149-55.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/jof6040253","article-title":"Comparison of \u03b2-D-glucan and galactomannan in serum for detection of invasive aspergillosis: retrospective analysis with focus on early diagnosis","volume":"6","author":"Dichtl K","year":"2020","unstructured":"Dichtl K, Forster J, Ormanns S, Horns H, Suerbaum S, Seybold U, Wagener J. Comparison of \u03b2-D-glucan and galactomannan in serum for detection of invasive aspergillosis: retrospective analysis with focus on early diagnosis. J Fungi (Basel). 2020, 6:10.3390\/jof6040253","journal-title":"J Fungi (Basel)"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.7326\/M13-2508","article-title":"Combination antifungal therapy for invasive aspergillosis: a randomized trial","volume":"162","author":"Marr KA","year":"2015","unstructured":"Marr KA, Schlamm HT, Herbrecht R, et al.. Combination antifungal therapy for invasive aspergillosis: a randomized trial. Ann Intern Med. 2015, 162:81-9. 10.7326\/M13-2508","journal-title":"Ann Intern Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/496510-role-of-the-fungal-serological-marker-galactomannan-antigen-in-the-diagnosis-of-invasive-fungal-infection-a-three-year-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T12:53:38Z","timestamp":1780145618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/496510-role-of-the-fungal-serological-marker-galactomannan-antigen-in-the-diagnosis-of-invasive-fungal-infection-a-three-year-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.109923","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,30]]}}}